Infection and Drug Resistance
Volume 13, 2020 - Issue
Open access
150
Views
14
CrossRef citations to date
0
Altmetric
Review
Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?
Mena Al-Ani1 Department of Clinical Sciences, College of Medicine and the Immuno-Oncology Group, Sharjah Institute for Medical Research, University of Sharjah, Sharjah27272, United Arab Emirates
, Noha Mousaad Elemam1 Department of Clinical Sciences, College of Medicine and the Immuno-Oncology Group, Sharjah Institute for Medical Research, University of Sharjah, Sharjah27272, United Arab Emirates
https://orcid.org/0000-0002-3586-6731
Jennifer Elisabeth Hundt2 Lübeck Institute for Experimental Dermatology, University of Lübeck, Lübeck, Germany
& Azzam A Maghazachi1 Department of Clinical Sciences, College of Medicine and the Immuno-Oncology Group, Sharjah Institute for Medical Research, University of Sharjah, Sharjah27272, United Arab EmiratesCorrespondence[email protected]
https://orcid.org/0000-0002-3310-678X
Pages 3243-3254
|
Published online: 22 Sep 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.